Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016.
Epidemiology
Pulmonary Fibrosis
Oncology and Carcinogenesis
Medical and Health Sciences
Vaccine Related
03 medical and health sciences
Rare Diseases
0302 clinical medicine
Theoretical and computational chemistry
Humans
Oncology & Carcinogenesis
Cancer
Evidence-Based Medicine
Biomedical and Clinical Sciences
Radiotherapy
Prevention
Oncology and carcinogenesis
Biological Sciences
National Cancer Institute (U.S.)
United States
3. Good health
Radiation Pneumonitis
Treatment Outcome
Physical Sciences
DOI:
10.1667/rr14784.1
Publication Date:
2017-05-10T16:23:38Z
AUTHORS (16)
ABSTRACT
A workshop entitled “Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate” (held in Rockville, MD, September 19, 2016) was organized by the Radiation Research Program and Radiation Oncology Branch of the Center for Cancer Research (CCR) of the National Cancer Institute (NCI), to identify critical research areas and directions that will advance the understanding of radiation-induced fibrosis (RIF) and accelerate the development of strategies to mitigate or treat it. Experts in radiation biology, radiation oncology and related fields met to identify and prioritize the key areas for future research and clinical translation. The consensus was that several known and newly identified targets can prevent or mitigate RIF in pre-clinical models. Further, basic and translational research and focused clinical trials are needed to identify optimal agents and strategies for therapeutic use. It was felt that optimally designed preclinical models are needed to better study biomarkers that predict for dev...
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (174)
CITATIONS (66)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....